STOCK TITAN

Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
partnership AI

Ainos (NASDAQ:AIMD) has expanded its strategic partnership with ASE Technology Holding (NYSE:ASX) to deploy up to 15,000 AI Nose units across ASE's global manufacturing network. The multi-phase rollout plan includes an evaluation phase with 1,400 units, Phase 1 with 5,000 units, and Phase 2 targeting up to 15,000 units.

The AI Nose platform will be used for real-time VOC anomaly detection, cleanroom environmental sensing, and automated ESG compliance monitoring. The partnership aims to advance smart factory transformation and environmental monitoring in semiconductor operations, with Ainos expecting to generate multi-million annual recurring revenue in the coming years.

Ainos (NASDAQ:AIMD) ha ampliato la sua partnership strategica con ASE Technology Holding (NYSE:ASX) per implementare fino a 15.000 unità AI Nose nella rete globale di produzione di ASE. Il piano di rollout, articolato in più fasi, prevede una fase di valutazione con 1.400 unità, la Fase 1 con 5.000 unità e la Fase 2 che punta a raggiungere fino a 15.000 unità.

La piattaforma AI Nose sarà utilizzata per il rilevamento in tempo reale di anomalie VOC, il monitoraggio ambientale delle camere bianche e il controllo automatico della conformità ESG. La partnership mira a promuovere la trasformazione delle fabbriche intelligenti e il monitoraggio ambientale nelle operazioni nel settore dei semiconduttori, con Ainos che prevede di generare ricavi ricorrenti annuali multimilionari nei prossimi anni.

Ainos (NASDAQ:AIMD) ha ampliado su asociación estratégica con ASE Technology Holding (NYSE:ASX) para desplegar hasta 15,000 unidades AI Nose en la red global de fabricación de ASE. El plan de implementación en varias fases incluye una fase de evaluación con 1,400 unidades, la Fase 1 con 5,000 unidades y la Fase 2 que apunta a alcanzar hasta 15,000 unidades.

La plataforma AI Nose se utilizará para la detección en tiempo real de anomalías VOC, el monitoreo ambiental de salas limpias y la supervisión automatizada del cumplimiento ESG. La asociación busca avanzar en la transformación de fábricas inteligentes y el monitoreo ambiental en operaciones de semiconductores, con Ainos esperando generar ingresos recurrentes anuales multimillonarios en los próximos años.

Ainos (NASDAQ:AIMD)ASE Technology Holding (NYSE:ASX)와의 전략적 파트너십을 확대하여 ASE의 글로벌 제조 네트워크에 최대 15,000대의 AI Nose 장치를 배치할 예정입니다. 다단계 롤아웃 계획은 1,400대의 평가 단계, 5,000대의 1단계, 최대 15,000대를 목표로 하는 2단계로 구성되어 있습니다.

AI Nose 플랫폼은 실시간 VOC 이상 감지, 클린룸 환경 감지 및 자동 ESG 준수 모니터링에 사용됩니다. 이 파트너십은 반도체 운영에서 스마트 팩토리 전환과 환경 모니터링을 촉진하는 것을 목표로 하며, Ainos는 향후 수년 내에 수백만 달러 규모의 연간 반복 수익을 창출할 것으로 기대하고 있습니다.

Ainos (NASDAQ:AIMD) a étendu son partenariat stratégique avec ASE Technology Holding (NYSE:ASX) pour déployer jusqu'à 15 000 unités AI Nose à travers le réseau mondial de fabrication d'ASE. Le plan de déploiement en plusieurs phases comprend une phase d'évaluation avec 1 400 unités, la Phase 1 avec 5 000 unités, et la Phase 2 visant jusqu'à 15 000 unités.

La plateforme AI Nose sera utilisée pour la détection en temps réel des anomalies de COV, la surveillance environnementale des salles blanches et le contrôle automatisé de la conformité ESG. Ce partenariat vise à faire progresser la transformation des usines intelligentes et la surveillance environnementale dans les opérations de semi-conducteurs, Ainos s'attendant à générer des revenus récurrents annuels de plusieurs millions dans les années à venir.

Ainos (NASDAQ:AIMD) hat seine strategische Partnerschaft mit ASE Technology Holding (NYSE:ASX) ausgeweitet, um bis zu 15.000 AI Nose Einheiten im globalen Fertigungsnetzwerk von ASE einzusetzen. Der mehrphasige Rollout-Plan umfasst eine Evaluierungsphase mit 1.400 Einheiten, Phase 1 mit 5.000 Einheiten und Phase 2 mit dem Ziel von bis zu 15.000 Einheiten.

Die AI Nose Plattform wird für die Echtzeit-Erkennung von VOC-Anomalien, die Überwachung der Reinraumumgebung und die automatisierte ESG-Konformitätskontrolle eingesetzt. Die Partnerschaft zielt darauf ab, die Transformation zu intelligenten Fabriken und die Umweltüberwachung in der Halbleiterfertigung voranzutreiben, wobei Ainos erwartet, in den kommenden Jahren mehrere Millionen an wiederkehrenden Jahresumsätzen zu generieren.

Positive
  • Potential deployment of up to 15,000 AI Nose units across ASE's global network
  • Partnership with world's leading semiconductor assembly and test services provider
  • Expected multi-million dollar annual recurring revenue potential
  • Strategic expansion into semiconductor industry with first-mover advantage
  • Integration with major players in robotics and smart factories (ugo and Kenmec)
Negative
  • Multi-phase deployment indicates extended timeline before full revenue realization
  • Success depends on evaluation phase performance
  • Implementation across multiple facilities may face integration challenges

Insights

Ainos' expanded partnership with ASE to deploy up to 15,000 AI Nose units represents significant revenue potential and industry validation.

Ainos' expanded strategic partnership with semiconductor giant ASE Technology Holding marks a significant commercial validation for their AI-driven scent digitization technology. The multi-phase deployment targeting up to 15,000 AI Nose units across ASE and SPIL facilities represents substantial scale compared to typical pilot projects in emerging technologies.

The phased approach is strategically sound: starting with 1,400 evaluation units, expanding to 5,000 units in critical areas, before potentially reaching 15,000 units at full deployment. This progressive adoption model reduces implementation risk while providing multiple validation points before full-scale commitment.

The company's mention of "multi-million annual revenue potential" indicates meaningful financial impact, especially notable for Ainos as a smaller technology provider partnering with ASE, the world's leading semiconductor assembly and test services provider. The recurring revenue model suggested in the release could establish predictable income streams if successful.

What's particularly valuable is how this deployment creates a reference architecture for other potential clients in advanced manufacturing. By establishing their technology in semiconductor facilities—environments with exceptionally stringent requirements—Ainos positions itself for expansion into other industrial sectors with similar or less demanding specifications.

The integration of scent digitization into cleanroom environments represents an innovative approach to environmental monitoring in semiconductor manufacturing, where even minute chemical variations can impact yields. By quantifying previously unmonitored environmental factors, this technology could potentially address production challenges that traditional sensors miss.

Ainos' "smell language model" (SLM) concept represents a genuine innovation in the sensory AI landscape, extending the machine learning paradigm beyond vision and language into olfaction. This positions Ainos in a distinctive niche with limited direct competition in the industrial AI market.

The technical approach parallels the development of visual language models (VLMs) but for scent—creating "Smell IDs" that enable machines to interpret and analyze olfactory data. This represents an untapped sensory dimension for industrial monitoring and could create a data moat if successfully implemented at scale.

What's particularly notable is the practical application focus. Rather than pursuing general-purpose olfaction (which presents enormous technical challenges), Ainos is targeting specific high-value use cases in controlled environments: VOC detection, cleanroom monitoring, and compliance—areas where even incremental improvements have substantial operational value.

The ASE partnership provides access to exceptionally controlled testing environments with clear ROI metrics. Semiconductor manufacturing represents an ideal proving ground as it combines stringent environmental requirements with high production values where minor improvements yield significant financial returns.

However, technical execution remains key. Digital olfaction is notoriously challenging given the complexity of scent signatures, sensor drift issues, and environmental variables. While the press release outlines commercial ambitions, actual performance metrics and technical specifications will determine whether this technology delivers sufficient value to justify the suggested 15,000-unit deployment.

Relationship Broadens Scope to Key ASE and SPIL Facilities with Multi-Phase Deployment

Milestone Positions ASEH and Ainos as First-Mover in AI-Powered Scent Intelligence for the Semiconductor Industry

SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 27, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") , a leader in AI-driven scent digitization, today announced the expansion of its strategic relationship with ASE Technology Holding Co., Ltd. ("ASEH", TWSE: 3711, NYSE: ASX), the world's leading provider of semiconductor assembly and test services. The two companies are contemplating a multi-phase roadmap to deploy Ainos' AI Nose platform across ASE's global manufacturing network, including facilities operated by Siliconware Precision Industries Co., Ltd. (SPIL).

This broadened relationship reflects both companies' commitment to advancing smart factory transformation, environmental monitoring, and sustainability in semiconductor operations.

"With recent collaborations including ugo in robotics and Kenmec in smart factories, we are rapidly scaling the reach of AI Nose across automation ecosystems," said Eddy Tsai, Chairman, President and CEO of Ainos. "This broadened relationship with ASEH further validates our technology and a significant global rollout opportunity. By converting scent into machine-readable Smell ID through our smell language model, we are introducing a new layer of environmental intelligence into semiconductor manufacturing."

"This is a major milestone in our mission to bring digital olfaction to industrial environments at scale. We also believe this deployment model can serve as a scalable reference for other advanced manufacturing clients worldwide, further advancing smart sensing and ESG integration. We could expect digital olfaction to generate stable recurring revenue for Ainos on an annual basis, with multi-million annual revenue potential in the coming years." Eddy added.

Multi-Phase Rollout Plan

The roadmap includes three phases:

  • Evaluation Phase: Deployment of approximately 1,400 AI Nose units across ASE and SPIL sites.

  • Phase 1: Expansion to approximately 5,000 units for integration across cleanrooms and production zones.

  • Phase 2: Full-scale deployment targeting up to 15,000 units.

Key use cases include:

  • Real-time VOC anomaly detection

  • Cleanroom and facility environmental sensing

  • Automated ESG compliance monitoring and reporting

AI Nose and Smell Language Model: A New Layer of Factory Intelligence

Just as visual language models (VLMs) allow machines to interpret sight, Ainos' AI Nose digitizes scent into Smell ID, training AI to understand scent signals. Ainos is on a journey to scale Smell ID into smell language model (SLM), a future enabling machines to "read" scent the way AI interprets test and images. This capability enhances environmental integrity, predictive safety, and sustainability reporting within smart factory systems.

The relationship further strengthens Ainos' role in the semiconductor value chain and positions AI Nose as a key enabling technology in global cleanroom and advanced packaging environments.

About Ainos, Inc.

Ainos, Inc. (NASDAQ: AIMD) is a dual-platform AI and biotech company pioneering SmellTech and immune therapeutics. Its AI Nose platform and Smell Language Model digitize scent into Smell ID, a machine-readable data format, powering applications across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Ainos, a fusion of "AI" and "Nose," is redefining machine perception for the sensory age. To learn more, visit https://www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.

About ASE Technology Holding Co., Ltd.

ASE Technology Holding is the leading provider of semiconductor manufacturing services in assembly and test. ASEH develops and offers complete turnkey solutions covering front-end engineering test, wafer probing and final test, as well as packaging, materials and electronic manufacturing services through USI with superior technologies, breakthrough innovations, and advanced development programs. With advanced technological capabilities and a global presence spanning Taiwan, China, South Korea, Japan, Singapore, Malaysia, Philippines, Vietnam, Mexico, and Tunisia as well as the United States and Europe, ASEH has established a reputation for reliable, high quality products and services. For more information, please visit https://www.aseglobal.com.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, our expectation that we will incur net losses for the foreseeable future; our ability to become profitable; our ability to raise additional capital to continue our product development; our ability to accurately predict our future operating results; our ability to advance our current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates we develop; the ability to obtain and maintain regulatory approval of our product candidates; delays in completing the development and commercialization of our current and future product candidates; developing and commercializing additional products, including diagnostic testing devices; our ability to compete in the marketplace; compliance with applicable laws, regulations and tariffs, and factors described in the Risk Factors section of our public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.

Contact Information

Feifei Shen
ir@ainos.com

SOURCE: Ainos, Inc.



View the original press release on ACCESS Newswire

FAQ

What is the scope of Ainos (NASDAQ:AIMD) partnership with ASE Technology?

The partnership involves deploying up to 15,000 AI Nose units across ASE's global manufacturing network, including SPIL facilities, through a multi-phase rollout plan.

How many AI Nose units will be deployed in the evaluation phase?

The evaluation phase will deploy approximately 1,400 AI Nose units across ASE and SPIL sites.

What are the main applications of Ainos AI Nose in semiconductor manufacturing?

The AI Nose platform will be used for real-time VOC anomaly detection, cleanroom and facility environmental sensing, and automated ESG compliance monitoring and reporting.

What is the revenue potential for Ainos (AIMD) from this partnership?

Ainos expects to generate multi-million dollar annual recurring revenue from digital olfaction technology in the coming years.

How is the AI Nose deployment structured across different phases?

The deployment includes three phases: evaluation phase with 1,400 units, Phase 1 with 5,000 units, and Phase 2 targeting up to 15,000 units.
Ainos Inc

NASDAQ:AIMD

AIMD Rankings

AIMD Latest News

AIMD Stock Data

10.59M
7.22M
72.61%
0.5%
1.69%
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN DIEGO